Literature DB >> 20035532

Skeletal muscle contractile properties and proinflammatory cytokine gene expression in human endotoxaemia.

F J McNicol1, J A Hoyland, R G Cooper, G L Carlson.   

Abstract

BACKGROUND: Muscle dysfunction associated with sepsis contributes to morbidity and mortality but the underlying mechanisms are unclear. This study examined whether muscle weakness relates to an intrinsic defect in contraction, or to central mechanisms associated with acute illness, and whether systemic endotoxaemia induces changes in gene expression for proinflammatory cytokines within human muscle in vivo.
METHODS: In this experimental study, 12 healthy men received intravenous Escherichia coli lipopolysaccharide (LPS, 4 ng/kg) or saline (control). Voluntary and electrically stimulated quadriceps contraction, and tumour necrosis factor (TNF) alpha mRNA expression in quadriceps muscle biopsies were studied before and after the infusion.
RESULTS: Endotoxaemia induced transient weakness of voluntary quadriceps contraction, equivalent to a 7.8 (95 per cent confidence interval 2.1 to 13.5) per cent reduction in contractile force at 180 min (P = 0.027) and a 9.0 (5.2 to 12.8) per cent reduction at 300 min (P = 0.008). Electrically stimulated contraction was unaffected. LPS administration resulted in an apparent fibre-specific induction of TNF-alpha mRNA.
CONCLUSION: Endotoxaemia results in a reduction in voluntary muscle contractile force without an apparent defect in stimulated muscle contraction. Loss of volition may be a more important factor than intrinsic dysfunction in acute sepsis-associated human muscle weakness. (c) 2009 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20035532     DOI: 10.1002/bjs.6868

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  9 in total

1.  Increasing motor neuron excitability to treat weakness in sepsis.

Authors:  Paul Nardelli; Randall Powers; Tim C Cope; Mark M Rich
Journal:  Ann Neurol       Date:  2017-12-07       Impact factor: 10.422

Review 2.  The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.

Authors:  O Friedrich; M B Reid; G Van den Berghe; I Vanhorebeek; G Hermans; M M Rich; L Larsson
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

3.  Loss of muscle strength during sepsis is in part regulated by glucocorticoids and is associated with reduced muscle fiber stiffness.

Authors:  Nima Alamdari; Gianluca Toraldo; Zaira Aversa; Ira Smith; Estibaliz Castillero; Guillaume Renaud; Rizwan Qaisar; Lars Larsson; Ravi Jasuja; Per-Olof Hasselgren
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-09-26       Impact factor: 3.619

4.  Reduced motor neuron excitability is an important contributor to weakness in a rat model of sepsis.

Authors:  Paul Nardelli; Jacob A Vincent; Randall Powers; Tim C Cope; Mark M Rich
Journal:  Exp Neurol       Date:  2016-04-24       Impact factor: 5.330

5.  The effect of autologous repair and voluntary wheel running on force recovery in a rat model of volumetric muscle loss.

Authors:  Tyrone A Washington; Richard A Perry; John T Kim; Wesley S Haynie; Nicholas P Greene; Jeffrey C Wolchok
Journal:  Exp Physiol       Date:  2021-03-02       Impact factor: 2.969

6.  Imbalanced Subthreshold Currents Following Sepsis and Chemotherapy: A Shared Mechanism Offering a New Therapeutic Target?

Authors:  Mark M Rich; Stephen N Housley; Paul Nardelli; Randall K Powers; Timothy C Cope
Journal:  Neuroscientist       Date:  2020-12-21       Impact factor: 7.235

7.  Early changes of muscle membrane properties in porcine faecal peritonitis.

Authors:  Karin A Ackermann; Hugh Bostock; Lukas Brander; Ralph Schröder; Siamak Djafarzadeh; Daniel Tuchscherer; Stephan M Jakob; Jukka Takala; Werner J Z'Graggen
Journal:  Crit Care       Date:  2014-08-22       Impact factor: 9.097

8.  Macrophages augment the skeletal muscle proinflammatory response through TNFα following LPS-induced acute lung injury.

Authors:  Joseph J Bivona; Hanna M Crymble; Blas A Guigni; Renee D Stapleton; D Clark Files; Michael J Toth; Matthew E Poynter; Benjamin T Suratt
Journal:  FASEB J       Date:  2021-04       Impact factor: 5.834

9.  SS-31 attenuates TNF-α induced cytokine release from C2C12 myotubes.

Authors:  Adam P Lightfoot; Giorgos K Sakellariou; Gareth A Nye; Francis McArdle; Malcolm J Jackson; Richard D Griffiths; Anne McArdle
Journal:  Redox Biol       Date:  2015-08-10       Impact factor: 11.799

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.